Scala Biodesign
Unique one-shot computational solution to dramatically increase the value and accelerate the development of proteins into commercial products.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | $5.5m | Seed | |
| Total Funding | 000k | ||
| USD | 2023 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Scala Bio is a cutting-edge biotechnology startup that focuses on optimizing the production and functionality of proteins, which are crucial for drug development and industrial applications. The company operates in the pharmaceutical, chemical, and sustainability markets, serving clients such as pharmaceutical companies, biotech firms, and industrial manufacturers.
Scala Bio's core business revolves around a proprietary platform that enhances the production yields and stability of membrane proteins and enzymes. Membrane proteins are essential for drug targets but are notoriously difficult to produce in large quantities. Scala Bio's technology addresses this challenge by optimizing production without compromising the proteins' activity. This is particularly valuable for drug screening and structural analysis.
In addition to membrane proteins, Scala Bio also improves the efficiency and selectivity of enzymes used in therapeutic and industrial applications. Enzymes are biological molecules that speed up chemical reactions, but many natural enzymes are not efficient or stable enough for commercial use. Scala Bio's platform can quickly enhance enzyme activity and stability, making them more suitable for various applications, from drug development to green manufacturing processes.
The company's business model is based on providing its proprietary technology as a service to its clients. Scala Bio makes money by offering solutions that accelerate the development of proteins into commercial products. This includes improving therapeutic enzymes, antibodies, vaccines, and industrial enzymes. By enhancing the stability, shelf life, and production yields of these proteins, Scala Bio adds significant value to its clients' products.
In summary, Scala Bio leverages advanced computational techniques to solve some of the most pressing challenges in biotechnology, making it a valuable partner for companies in the pharmaceutical, chemical, and sustainability sectors.
Keywords: biotechnology, protein optimization, membrane proteins, enzyme efficiency, drug development, industrial applications, computational solutions, pharmaceutical, chemical, sustainability.